Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans by Colangeli, Roberto et al.
Whole Genome Sequencing of Mycobacterium
tuberculosis Reveals Slow Growth and Low Mutation
Rates during Latent Infections in Humans
Roberto Colangeli1, Vic L. Arcus2, Ray T. Cursons2, Ali Ruthe2, Noel Karalus5, Kathy Coley6,
Shannon D. Manning4, Soyeon Kim3, Emily Marchiano1, David Alland1*
1Department of Medicine, Rutgers-New Jersey Medical School, Newark, New Jersey, United States of America, 2Department of Biological Sciences, University of Waikato,
Hamilton, New Zealand, 3Department of Preventive Medicine, Rutgers-New Jersey Medical School, Newark, New Jersey, United States of America, 4Department of
Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, United States of America, 5 Respiratory Research Unit, Waikato Hospital,
Hamilton, New Zealand, 6Department of Pathology, Waikato Hospital, Hamilton, New Zealand
Abstract
Very little is known about the growth and mutation rates of Mycobacterium tuberculosis during latent infection in humans.
However, studies in rhesus macaques have suggested that latent infections have mutation rates that are higher than that
observed during active tuberculosis disease. Elevated mutation rates are presumed risk factors for the development of drug
resistance. Therefore, the investigation of mutation rates during human latency is of high importance. We performed whole
genome mutation analysis of M. tuberculosis isolates from a multi-decade tuberculosis outbreak of the New Zealand
Rangipo strain. We used epidemiological and phylogenetic analysis to identify four cases of tuberculosis acquired from the
same index case. Two of the tuberculosis cases occurred within two years of exposure and were classified as recently
transmitted tuberculosis. Two other cases occurred more than 20 years after exposure and were classified as reactivation of
latent M. tuberculosis infections. Mutation rates were compared between the two recently transmitted pairs versus the two
latent pairs. Mean mutation rates assuming 20 hour generation times were 5.5X10210 mutations/bp/generation for recently
transmitted tuberculosis and 7.3X10211 mutations/bp/generation for latent tuberculosis. Generation time versus mutation
rate curves were also significantly higher for recently transmitted tuberculosis across all replication rates (p = 0.006).
Assuming identical replication and mutation rates among all isolates in the final two years before disease reactivation, the
u20hr mutation rate attributable to the remaining latent period was 1.6610211 mutations/bp/generation, or approximately
30 fold less than that calculated during the two years immediately before disease. Mutations attributable to oxidative stress
as might be caused by bacterial exposure to the host immune system were not increased in latent infections. In conclusion,
we did not find any evidence to suggest elevated mutation rates during tuberculosis latency in humans, unlike the situation
in rhesus macaques.
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Introduction
Approximately one-third of the world’s population is asymp-
tomatically infected with Mycobacterium tuberculosis [1]. M. tuberculosis
may persist in a latent state for the life of its human host, or may
reactivate after months to years, causing symptomatic tuberculosis
disease. The world’s latently infected population comprises the
reservoir which feeds the global tuberculosis epidemic. Therefore,
novel approaches to treat and eradicate latent infections would
contribute greatly to tuberculosis control and eventual eradication.
Recent immunological studies of latent tuberculosis suggest that
latency encompasses a disease spectrum that extends from non-
replicating persisting organisms, to replicating but asymptomatic
infections, to low level-disease with higher numbers of actively
replicating bacteria [2] [3]. A better understanding of the bacterial
replication rates occuring during latency would help in the design
of drug regimens to treat LTBI. Replicating organisms are
susceptible to drugs that target pathways required for cellular
growth. Several commonly used anti-tuberculosis drugs fall into
this category. On the other hand, non-replicating organisms are
much more tolerant to these drug classes [4] [5]. Another
unknown feature of latency is the mutational capacity of the latent
M. tuberculosis bacilli. The presumed intracellular location and
prolonged exposure of latently infecting M. tuberculosis to reactive
effecter molecules of the host immune system could predispose
latent organisms to enhanced rates of mutation [6]. Rapidly
mutating organisms are more likely to undergo selection for drug
resistance. Thus, our understanding of replication and mutagen-
esis in latent M. tuberculosis has clear implications for treatment
strategies to eradicate latency.
The replication and mutation rates which occur during latency
are difficult to individually verify experimentally. However, a
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curve which describes mutation rates as a function of replication
(expressed in generation times) can be calculated by measuring the
number of chromosomal mutations that occur over a defined
period of infection [6]. Recent studies in rhesus macaques have
shown that the generation-time versus mutation-rate (GT vs MR)
curves of M. tuberculosis isolated from latent lesions and reactivated
infection are surprisingly similar to those of M. tuberculosis isolated
from active pulmonary disease [6]. These observations suggest
either that latent and disease-causing M. tuberculosis have strikingly
similar replication and mutation rates, or that latent M. tuberculosis
has lower replication rates than disease-causing M. tuberculosis, but
has substantially higher mutation rates.
We considered the possibility that the non-human primate
model might not appropriately recapitulate latent tuberculosis in
humans. Latent tuberculosis cannot be isolated from living
humans. However, GT vs MR curves during latency may be
inferred from the genome sequence of strains isolated from
subjects who develop tuberculosis disease after a long latency
period in comparison to the genome sequence of the strain isolated
from the original index case. A similar analysis of strains isolated
from recently transmitted tuberculosis cases can serve as a
comparator group. This type of analysis must be performed using
strains from a well defined tuberculosis outbreak caused by an
easily identifiable clone, preferably in a setting where the
background tuberculosis infection rate with confounding strains
is low. The multi-decade outbreak of the M. tuberculosis Rangipo
strain in New Zealand provided us with such an opportunity to
study M. tuberculosis replication and mutation rates in tuberculosis
disease caused by recently transmitted M. tuberculosis versus disease
that developed after a long latency period [7]. This investigation
describes the first study of latent M. tuberculosis bacteria in humans.
Results
Epidemiology of outbreak
Over the past several decades, an M. tuberculosis strain locally
known as the Rangipo strain has been responsible for a number of
tuberculosis outbreaks in New Zealand. Tuberculosis incidence
rates in the central North Island have been constant over this
period (1991–2011) at ,8 per 100,000, however outbreaks of the
Rangipo strain have resulted in local spikes in incidence rates. For
example, an outbreak of this strain in the Hawkes Bay region
increased incidence rates from a baseline of 8.7 per 100,000 before
1988 to a rate of 20.9 per 100,000 for the period between 1988
and 2002. The Rangipo strain has been typed using IS6110-based
DNA fingerprinting and is the largest single M. tuberculosis cluster
in New Zealand representing over 12% of cluster cases (57 cases
over 5 year period). [8] This strain is significantly more likely to
infect people of Maori or Pacific ethnicity and people under the
age of 20 years.
We investigated a single-source Rangipo strain cluster plus
same-strain controls (Fig. 1) that occurred over a 20 year period in
central North Island of New Zealand. Subject ‘‘X’’ developed
Rangipo-strain tuberculosis in 1990 and appears to the index cases
for the cluster of interest. The sibling and close contact of X,
subject ‘‘C1’’ was subsequently diagnosed with culture-positive
tuberculosis in 1992. Subject C1 was treated and appeared to be
cured of tuberculosis, but the subject again developed tuberculosis
17 years later in 2009 (now called subject ‘‘C2’’). C2 had also
developed diabetes by this time. Subject ’’E’’ was a close contact of
subject X, who developed tuberculosis meningitis in 1992.
Subjects ‘‘S’’ and ‘‘O’’ were also close contacts with subject ‘‘X’’
in the early 1990’s. S developed tuberculosis in 2010 and O
developed tuberculosis in 2008. For control cultures, we selected
other tuberculosis cases caused by the Rangipo-strain in the same
region of New Zealand from subjects who did not have any known
contacts with subject X, or with subjects E, C1/C2, or, S. Subject
‘‘A’’ had tuberculosis in 1991 at the age of 35. Subject ‘‘T’’ was the
parent of subject ‘‘A’’. T had close contact with A during the time
that A had active tuberculosis in the 1990’s; however, T did not
develop tuberculosis until in 2010. Subject ‘‘F’’ was a 3 year old
child who had tuberculosis in 1996. Subjects ‘‘N’’, ‘‘O’’, and ‘‘U’’
developed tuberculosis in 2007, 2008 and 2011, respectively.
Identification of polymorphisms among M. tuberculosis
NZ isolates
We sequenced the complete genomes of all 10 outbreak and
control M. tuberculosis strains to establish their phylogenetic
relationships and to estimate the replication and mutation rates
of various isolate pairs. Paired isolates X – E, X- C1 were assumed
to represent recently-transmitted tuberculosis (RT-TB) with
subsequent progression or early-reactivation to disease because E
and C1 developed tuberculosis within two years of exposure to X’s
tuberculosis. X – S, X – O, C1 – C2 and A – T pairs were
assumed to represent latent tuberculosis (L-TB) with late-
reactivation to disease because S, O, and T developed tuberculosis
.10 years after exposure to their index case, and C2 developed a
second case of tuberculosis 17 year after apparently successful
treatment for this subject’s (C1) first tuberculosis episode.
Genome coverage averaged 98% across these isolates, and the
average read depth was 120X across the genomes (Table S1). A
total of 747 SNPs were found between the H37Rv strain reference
genome and the study isolates. After eliminating SNP differences
with H37Rv that were shared by all 10 sequenced isolates, SNPs in
repetitive sequences, and errors in SNP calls discovered by our
Sanger re-sequencing efforts, we identified a total of 34 SNPs in
the 10 sequenced genomes. In no case did we find a confirmed
SNP between two colonies isolated from the same subject sample.
Thus, all subsequent analyses were performed on a per-subject
basis (Table 1). The isolates from each subject differed from each
other subject isolate by a minimum of 1 SNPs and a maximum of
14 SNPs (Table 2). We examined the types of genes which were
mutated between our study subjects. The mutations did not cluster
into any particular gene or functional type. SNPs were identified in
genes belong to secreted antigen (3/34); hypothetical proteins (6/
34); membranes associated and transport proteins (4/34);
transcriptional regulators (5/34); enzymes for degradation or
biosynthesis (10/34); proteases (2/34); and factors involved in
translation (2/34).
Phylogenetic analysis
A phylogenetic analysis of all 34 SNPs from the 10 Rangipo
genomes was performed. Five of the SNPs appeared to be
homoplastic, as indicated by the parallelograms shown in a
network analysis (Fig. 2A); however, a pairwise homoplasy index
test for recombination could not be performed due to the small
number of SNPs evaluated. Homoplasy suggests either convergent
evolution of independent mutational events or lateral gene
exchange (although gene exchange appears to be uncommon in
M. tuberculosis) [9]. The 34 SNP phylogenetic analysis supported
the epidemiological connections identified between subjects X - E,
X - C1, and X - S. However, a direct connection between X and
O was somewhat less certain given that S and O shared one SNP
each in fadE21 and ild2 that were not present in X (Table 1).
Surprisingly, the phylogenetic analysis suggested that C2 did not
have C1 as its most recent ancestor even though subject C2 was in
fact the same person as subject C1. Similarly, isolate T was
confirmed to not have isolate A as its most recent ancestor, even
M. tuberculosis, Mutation Rates Humans
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though we had originally assumed that subject T had contracted
tuberculosis from his/her child, subject A. Similar phylogenetic
relationships were observed in a 34 SNP analysis using the
Neighbor-joining method with rooting on M. tuberculosis strain
H37Rv (Fig. 2B).
Homoplasy can interfere with an accurate phylogenetic analysis
[10]. Therefore, we reasoned that a more accurate description of
isolate relationships and ancestry would be obtained by perform-
ing a phylogenetic analysis that included only the 29 non-
parsimonious SNPs using the Neighbor-joining method (Fig. 2C).
In this analysis, all isolates except that from subject T shared a
common root, and X was the most deeply rooted subject. This
analysis further confirmed the close ancestry of the X – E, X – C1,
and X – S strain pairs, and strongly supported the epidemiolog-
ically suggested ancestry of the X – O strain pair. As in the 34 SNP
analyses, the 29 SNP analysis also indicated that isolate C2 did not
have isolate C1 as its most recent ancestor; and isolate T did not
have A as its most recent ancestor. These results demonstrate that
epidemiological connections such as presumed relapse, or close
contact between a child and parent do not conclusively prove
ancestry in an outbreak investigation, even if the isolates have
matched DNA fingerprints.
We looked for additional ways to test whether O and S were
caused by reactivation of a latent infection acquired from X
around 1990, or were instead acquired more recently from
Rangipo strains circulating in the community during the past
decade. We reasoned that reactivated latent infections should be
similar to other strains such as E and C1, isolated from contacts
with X in the 1990s as measured by SNP distance. In contrast,
more recently acquired infections should be more similar to stains
circulating in the past decade, such as T, C2 N and U. Indeed, the
mean SNP distance (Table 2) among O, S, E and C1 was 2.8,
while the mean SNP distance among O, S, T, C2, N and U was
6.4, with a two sided p-value of 0.057. While the difference
between these two groups did not quite reach statistical
significance, the trend for significant difference was quite strong.
These results further support our conclusion that S and O derive
from reactivation of a latent X infection instead of infection from a
more recently circulating Rangipo strain.
Mutation rates among M. tuberculosis isolates
We examined the mutation rates for each isolate pair; after
elimination pairs A–T and C1–C2 due to the lack of phylogenetic
support for direct ancestry. We estimated the mutation rate
mutation/bp/generation across a broad range of generation times,
and also derived a mutation rate at an assumed 20 hour
generation time (u20hr) as described previously [6]. Our results
differed strikingly from those derived from rhesus macaques. The
estimated u20hr mutation rate for the RT-TB isolate pairs X-C1
and X-E was 8.2610210 and 2.7610210 mutations/bp/genera-
tion respectively, while for the L-TB isolate pairs X-S and X-O,
the u20h was 5.4610211 and 9.1610211 mutations/bp/genera-
tion. The GT vs MR curves of the RT-TB isolate pairs also
differed markedly compared to the L-TB isolate pairs (Fig 3A). If a
common generation time is assumed, the estimated mean
mutation rates per generation or alternatively the mean number
of mutations per calendar year of the RT-TB isolate pairs was
approximately 10-fold higher than those of the L-TB isolate pairs
(Fig 3B), with a significant difference of p = 0.006 between the two
conditions.
Even though the L-TB isolates experienced a long period of
latency, they ultimately reactivated to cause clinical tuberculosis.
Thus, a period of the L-TB isolate lifecycle may have been similar
to that of the RT-TB isolates including replication and mutation
rates similar to the RT-TB isolates. We wished to specifically study
the mutation versus replication rates of the latency period. For
these calculations, we made the assumption that the RT-TB and
L-TB isolate groups have identical replication and mutation rates
Figure 1. Epidemiological relationships among 11 New ZealandM. tuberculosis cases. Chronological representation of different subjects in
a New Zealand TB outbreak. Each square represent a subject at the time of the TB diagnosis. Broken lines represent known close direct contact with
the initial index case ‘‘X’’ during X’s period of infectiousness. Solid lines show assumed connections between a case of presumed reactivation (C1 to
C2) and a case of potential child-parent transmission (A to T).
doi:10.1371/journal.pone.0091024.g001
M. tuberculosis, Mutation Rates Humans
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in the two years preceding the onset of each subject’s clinical
disease (Fig. 4A). Adjusting for this two-year period, we calculated
the u20hr mutation rate attributable to the remaining latent
period to be 1.6610211 mutations/bp/generation, or approxi-
mately 30 fold less than that calculated during the final two years
before disease. The GT vs MR curves were similarly depressed
(Fig 4B). In fact, we found that the mutation rate during the
modeled latent period at a generation time of 240 hours (the end
of our scale) was lower than the mutation rate at a generation time
of 18 hours (the beginning of our scale) during the modeled two
years before disease period. These results strongly suggest that
replication rates and/or mutation rates are markedly lower during
the latent stage of disease compared to the two-year period up to
and including active tuberculosis.
Finally, we compared the type of mutations which developed in
the RT-TB versus the L-TB groups to determine the degree to
which oxidative damage could account for mutation rates. We
looked for footprints of oxidative damage reflected by either
cytosine deamination (GC to AT changes), or the formation of 8-
oxoguanine (GC to TA changes) [11] [12]. A total of 10 SNPs
were detected among the four isolate pairs. All four of the
mutations present in the RT-TB group were indicative of
oxidative damage (Fig 5). In contrast only three of six mutations
in the L-TB group were of this type. Thus, half of the mutations in
the L-TB group can be attributed to replicative mutagenesis rather
Table 1. Single nucleotide polymorphisms identified in sequenced isolates.
Strain
A C1 E F N O C2 S T U H37Rv1
Gene
Rv3705c - - - - - - A - - - G
Rv3519 - - - - - - A - - - T
Rv3555c - - - - - - - - C - G
Rv1081c - - - - A - - - - - C
mutA - - - - - - - - G - A
Rv0024 - - - - C - - - - - A
Rv2333c - A - - - - - - - - G
Rv0047c - - - - - - - - A - G
Rv0338c - - - - - - T - - - C
Rv0241c - - - - - A - - - - C
ctpF - A - - - - - - - - G
adhE1 - - - - - - - - T - C
Rv2689c - - - - - - T - - - C
bioF2 - - - - - - - - C - G
esxO - - - - A - - - - - G
ppsD G - - - - - - - - - T
clpX - - - - - C - - - - T
fadD34 - - - - C - - - - - G
Rv2282c - - - - - - - - - G A
oxyS - T - - - - - - - - G
nirB - - - - - - - - - T C
infB - - - - - - - - - G T
Rv1626 - - - - - - - - T - C
valS - - - - T - - - - - G
Rv1231c - - - - - - - - T - C
Rv3559c - - - - - - - - G - C
glnA2 - - - - - - - - - G A
Rv0737 - - - A - - - - - - C
clpB - - - A A - - - - - G
Rv3586 - - - A A - - - - - G
Rv1422 - - T - - - - - - - C
lldD2 T - - - T T T T T T C
fadE21 G - - - G G G G G G A
Rv3213c - - - - - - - - A - G
1reference genome.
doi:10.1371/journal.pone.0091024.t001
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than oxidative stress. It is not possible to know which mutations
occurred during the prolonged latency period versus the acceler-
ated replication rates that we presume to have occurred just prior
to and during active disease. However, our results do not suggest a
higher rate of oxidative-damage induced mutagenesis during the
latent phase compared to the phase of active tuberculosis in
humans, which contrasts strongly with rhesus macaques.
Discussion
It is understandably difficult to investigate the biology of the M.
tuberculosis during latent human infections. M. tuberculosis can cause
years of asymptomatic infection, only to reactivate when the host
immune system is perturbed, or by other unknown causes. It is
difficult or impossible to culture M. tuberculosis from these
asymptomatic individuals until they develop symptomatic disease.
Latent tuberculosis is instead detected by way of the host immune
response. We were able to estimate the replication and mutation
rate of latent M. tuberculosis bacilli by comparing the genome
sequence of a single strain that had been transmitted from a single
index case, causing disease in close contacts over a period of .20
years. We found that mutation rates were substantially lower
during latency for any given generation time, especially after we
adjusted for the higher mutation rates that were likely to have
occurred during the final phase of each subject’s infection, as they
developed active tuberculosis.
Our study did not enable us to separately calculate replication
and mutation rates for the conditions under investigation. Instead,
each parameter could only be considered as a function of the
other. However, latency is defined by an absence of symptoms,
which suggests that replication rates are likely to be lower during
latency than they are during active clinical tuberculosis. Assuming
that this is true, our results are best explained by a picture of
latency that involves low replication rates and low mutation rates
compared to active tuberculosis. Our conclusions are further
Table 2. Number of single nucleotide polymorphisms differences between each strain.
Strain X Strain C1 Strain E Strain S Strain A Strain F Strain N Strain O Strain C2 Strain T
Strain X 0
Strain C1 3 0
Strain E 1 4 0
Strain S 2 3 1 0
Strain A 3 4 2 1 0
Strain F 3 4 2 1 2 0
Strain N 9 8 6 5 6 6 0
Strain O 4 5 3 2 3 3 7 0
Strain C2 6 7 5 4 5 5 9 6 0
Strain T 11 12 10 9 10 10 14 11 13 0
Strain U 6 6 4 3 4 4 8 5 7 12
doi:10.1371/journal.pone.0091024.t002
Figure 2. Evolutionary history of M. tuberculosis strains isolated from a cluster of cases in New Zealand. Relationships were inferred by
examining parsimony and nonparsimony informative single nucleotide polymorphisms (SNPs). Panel A: parallelogram of network analysis using 34
SNPs including five homoplastic SNPs. Panel B: Evolutionary tree using the same 34 SNPs as in A rooted on M. tuberculosis H37Rv analyzed using
Neighbor-joining method. Panel C. Evolutionary tree examining 29 nonparsimony SNPs using the Neighbor-joining method. The evolutionary
distances represent the number of SNP differences per strain.
doi:10.1371/journal.pone.0091024.g002
M. tuberculosis, Mutation Rates Humans
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supported by the fact that mutations attributable to oxidative stress
were not found in a higher proportion of the L-TB isolate pairs
compared to the RT-TB pairs, rather the opposite was true. This
observation also contrasts to the situation in rhesus macaques.
Although our analysis was relative small (based on four pair-wise
comparisons), it is comparable to the sample size used in the rhesus
macaques studies were four animals were used for active disease,
three for latent and two for reactivation. Furthermore, although
different M. tuberculosis lineages have been found to have different
intrinsic mutation rates during in vitro culture [6], the Rangipo
strain is a member of lineage 4, which is the same group as the
Erdman and H37Rv strain used in the macaque study. In addition,
the close SNP-defined relationship among all of the study isolates
strongly suggests that our results are not due to differences in
intrinsic mutation rates between L-TB and RT-TB isolates. Thus,
it appears that human latency may differ markedly from latency in
non-human primates. Human latency appears to lie on the
quiescent end of the disease spectrum while latency in rhesus
macaques appears to be closer to active disease. We were only able
to study two subjects with long periods of latent infection;
therefore, it is certainly possible that a much broader spectrum of
replication and mutation rates exists among the billions of humans
with latent tuberculosis infection. Our results will need to be
Figure 3. In vivo mutation rates inM. tuberculosis strains for generation times ranging from 18 to 240 hours. The mutation rate for each
of the M. tuberculosis isolates was estimated using equation (1) in Ford et al, and calculated as untis of mutation/bp/generation Panel A: The
mutation rate for each M. tuberculosis isolate in the study. Isolate C1 and E are from recent infection while strains O and S from reactivation after a
prolonged period of latency. The yellow areas represent 95% confidence intervals. Panel B: Isolates with recent infection (E and C1) and reactivation
after prolonged latency (O and S) were combined to obtain overall estimates of mutation rates of recent and latent-reactivated disease. The yellow
areas represent 95% confidence intervals.
doi:10.1371/journal.pone.0091024.g003
M. tuberculosis, Mutation Rates Humans
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validated in larger studies, with different patient populations and
M. tuberculosis strain types.
We did not find evidence that latent M. tuberculosis bacilli are
under excessive oxidative mutational stress during latency,
suggesting that mutational drug resistance is unlikely to occur
during a latent infection, especially if the bacterial burden is low. It
follows that latent infection is likely to be safely treatable with
single drugs, as is common practice. The risk for mutational drug
resistance would be expected to rise as a latent infection begins to
progress to active tuberculosis disease, however. Thus, multi-drug
therapy might be considered to prevent resistance from developing
during latent infections that are deemed to be at high risk for rapid
reactivitation, as might be the case after a known recent exposure
to a tuberculosis case. Immunological assays of host response or
more sensitive diagnostic assays to detect rare M. tuberculosis
organisms may be needed to distinguish between the latent and
early disease states.
Our results help to confirm the hypothesis that improved drugs
targeting latent M. tuberculosis might be able to work through novel
mechanisms which kill non-replicating or slowly replicating
organisms. Several new anti-tuberculosis drugs under development
may be suitable and should be studied for this purpose. On the
Figure 4. Mutation versus replication rates during the latency period. To evaluate if the mutation rate was different in early versus late
period of latent-reactivated disease, we estimated the mutation rate (calculated as untis of mutation/bp/generation) for isolates with reactivation of
TB for the latent and reactivated years. Panel A: A schematic representation for the evaluation of the rate of mutation in the latency period. The
mutation rate of the recent activated TB (strains C1 and E) was subtracted from the late activated TB (strains O and S).Panel B: The mutation rate for
the latent period was calculated using the difference between the number of mutations for the early reactivation phase and the late reactivated
phase. The result was divided by the genome size multiplied by the number of generations for O and S combined in the presumed latent period. All
these calculations implicitly assume a homogeneous mutation rate across the genome and over time and when combining activation groups, across
isolates. Analyses were performed using PROC GENMOD in SAS 9.2 (SAS Institute Inc, Cary, NC). Graphics were generated using R 2.12.2 (R Foundation
for Statistical Computing).
doi:10.1371/journal.pone.0091024.g004
Figure 5. Different type of mutations among recent and latent
reactivated M. tuberculosis isolates. Isolates from subjects with
recent (Gray) and latent (Black) reactivated tuberculosis were analyzed
for different mutations types. GC.AT and GC.TA mutations represent
changes potentially due to oxidative damage.
doi:10.1371/journal.pone.0091024.g005
M. tuberculosis, Mutation Rates Humans
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other hand, our results suggest that replication does take place in
latent M. tuberculosis, infection, albeit at a slow rate. These findings
help to explain how drugs such as isoniazid, which only kill
replicating bacteria, can effectively eradicate latent infections
when treatment is extended for nine months.
Our study is consistent with and expands on other whole
genome sequencing studies of clinical M. tuberculosis isolates.
Sandegren et al. showed that the M. tuberculosis genome is quite
stable in a serial chain of transmission across 115 subjects [13].
Others have described the utility of whole genome sequencing in
defining tuberculosis outbreaks [14] [15]. As in our study,
Namouchi et al. [16] detected homoplastic SNPs on the terminal
branches of an M. tuberculosis phylogenetic tree, suggesting that
convergent evolution or lateral gene exchange can occur. Our
study also provides a number of new insights into the use of
common molecular epidemiological methods and tools. Classical
epidemiology and molecular fingerprinting had suggested the
isolate C2 could be attributed to relapse tuberculosis in subject C1.
In a similar manner, subject T appeared to have acquired
tuberculosis from subject A. Our phylogenetic analysis suggests
that neither of these strong epidemiologic connections explained
the origin of these two cases. As powerful as whole genome
sequencing may be for establishing transmission links and strain
identification, our results emphasize the importance of including
same-strain controls and performing detailed phylogenetic anal-
yses of all samples.
In summary, this study provides the first estimates of replication
and mutation rates in latent human tuberculosis, and strongly
supports the concept that latent tuberculosis in humans differs
from that documented in rhesus macaques. Our results suggest
that human latency can include prolonged periods with very low
replication rates and only moderate rates of mutations. These
results demonstrate the important contributions and limitations of
whole genome sequencing in the study of latency. Further
investigations will be required to fully elucidate the biological
features of this disease state.
Methods
Bacteria culture and DNA isolation
M. tuberculosis isolates from New Zealand were collected as
follows: Clinical samples were cultured on Lowenstein Jensen (LJ)
slopes, and in Bactec 12B medium, a modified Middlebrook broth
supplemented with OADC enrichment and PANTA antibiotic
mixture. Isolates collected in the late 1990’s were cultured on LJ
slopes and Mycobacteria Growth Index Tubes (MGIT). After
isolation, cultures were stored in Middlebrook 7H9 broth/MGIT
broth at 270uC. M. tuberculosis from these New Zealand cultures
were then subcultured at 37 C on Middlebrook 7H10 media
(Difco, Detroit, Mich.) containing 0.05% Tween 80, 0.02%
glycerol, and 10% OADC. Two individual colonies from each
original culture were selected at random, cultured to mid log phase
in Middlebrook 7H9 media containing 0.05% Tween 80, 0.02%
glycerol, and 10% OADC then plated onto 7H10 media to obtain
confluent growth. After substantial colony growth was observed,
all of the colonies on each plate were scraped into water and then
DNA from these pooled colonies was isolated using a hexadecyl-
trimethylammonium bromide (CTAB) extraction protocol as
described previously [17]. All the M. tuberculosis isolates were part
of a single outbreak of the Rangipo strain [8] with a MIRU
pattern for completeness of 233 325 153 324 341 444 223 362.
Genome Sequencing
Barcoded libraries were prepared by shearing genomic DNA to
100 to 400 according to the manufacturer’s recommendation
(Applied Biosystems (ABI), Foster City, CA P/N 4443713). Each
library was ligated to the prepared DNA and the libraries were
nick translated and amplified using multiplex library PCR primers.
After multiple purification steps the DNA was mounted on the
SOLiD 5500XL instrument (ABI). Data was collected for each
cycle in the Instrument Control Software (ICS) and transferred to
the server where analysis is performed in the SOLiD Experimental
Tracking Software (SETS). The overall fold coverage for each M.
tuberculosis strain ranged between 392 and 40, while the fraction
covered by the sequence ranged from 0.96 to 1.00 (Table S1). The
pipeline analysis was performed using CLC Genomics Workbench
(CLCbio, Denmark). After uploading the data files to the CLC
server the sequence reads were trimmed to remove short and low
quality reads (length .20 bases, quality$0.05) and mapped to the
Mtb genome (NCBI accession #N000962) [18]. All statistical
information was derived from the resulting table generated by the
software. Sequences with multiple alignments to the reference
strain were removed, these sequences principally corresponded to
the highly repetitive PE/PPE, PE-PGRS gene families and mobile
genetic elements. We also removed alignments with,10X
coverage.
Mutation detection and confirmation
After trimming, CLC Genomics Workbench was used to
identify single nucleotide polymorphisms (SNPs) in the subject
sequences compared to the H37Rv genome. SNPs were discarded
if ,80 of the reads showed this polymorphism. All of the loci that
were mutant in at least one study isolate were concatenated for
each sequenced genome. However, M. tuberculosis cultures were not
available for subject X, therefore this subject’s concatenated
sequence was created using the consensus of the subject E and C
(close contacts of subject X) concatenations. The subject S
concatenation was used to break a tie when subject E and C
differed. Mutations found to be common to all of the study isolates
compared to the reference strain were eliminated. Mutations
unique to one subject but present in both colonies from that
subject (concordant paired mutations) were accepted without
further evaluation after an initial Sanger sequencing test of four
concordant pair mutations confirmed sequence accuracy in this
situation). Discordant paired mutations were analyzed using CLC
Genomics Workbench and mutations which were near the
predefined cutoffs were confirmed by Sanger sequencing of both
paired isolates. DNA sequencing primers are listed in Table S2.
Phylogenetic analysis
A total of 34 SNPs representing the 10 strains were
concatenated and aligned in MEGA 5.05 [19] and the evolution-
ary history was inferred using the Neighbor-Joining method [20]
with bootstrap confidence values (1000 replications) [21]. The
evolutionary distances were computed using the p-distance
method [22] and are represented as the number of base distances
per site. Additionally, a phylogenetic network was constructed
using the Neighbor-net algorithm [23], which was applied to 30
parsimonious informative sites using SplitsTree4 [24].Trees were
constructed with and without Rv as an outgroup.
Statistical analysis and estimation of mutation rate
As in Ford et al, [6] the mutation rate for each strain was
estimated from the number of SNPs observed divided by the
number of generations, where the number of generations was
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calculated from the time to (re)activation divided by the generation
time which was varied between 18 and 240 hours. A Poisson
model was assumed for the number of SNPs with offsets used to
normalize the rates to the (re)activation time. The 95% confidence
intervals using the profile likelihood were calculated on the log
scale and transformed to the original scale. Analyses were
performed using PROC GENMOD in SAS 9.2 (SAS Institute
Inc, Cary, NC). Graphics were generated using R 2.12.2 (R
Foundation for Statistical Computing). To test whether strains
epidemiologically linked to X had shorter SNP distances within
the group compared to those occurring between 2000–2011 and
were not linked to X, we generated all permutations of four cases
and generated the average SNP distance within the group by
generating all pairs within the groups of 4. We compared the
average SNP distance for the observed epidemiologically linked
group (S, O, E, C1) to the permutation distribution to obtain an
exact two-sided p-value.
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